Vagina Size and Sexual Pleasure: Does Size Matter?

The size of a woman’s vagina and its impact on sexual pleasure have been debated, with limited research on the topic. Vaginas are highly elastic and can change in size to accommodate different activities such as childbirth and sexual arousal. Women may experience discomfort during sex due to factors such as muscular weakness or injury,…

Read More

How Common Is It in Patients on Dupilumab?

A study found that 2% of patients taking dupilumab for atopic dermatitis (AD) are likely to experience conjunctivitis, with occurrences happening most frequently within the first 16 weeks of therapy. Developed for AD treatment, dupilumab inhibits signaling of interleukin (IL)-4 and IL-13, found in inflammatory diseases like AD, asthma, and others. In a study of…

Read More

An Alternative Approach To Treat Obesity? Scientists Develop Vibrating, Ingestible Capsule That Makes You Feel Full

Researchers have developed an ingestible capsule that vibrates in the stomach to create a sense of fullness and reduce food intake by about 40%. The capsule was tested on animals and found to stimulate the release of hormones that signal satiety. When vibrating, hormone levels closely mimicked patterns seen after eating. The current version of…

Read More

Health Bulletin 30/December/2023

The health bulletin for 30th December 2023 discusses the use of cookies for analytics, advertising, and site improvement. Users are asked to agree to the use of cookies by continuing to use the site. Further information about the use of cookies can be found in the Cookie Policy and Cookie Settings. Source link

Read More

PERSEUS trial results ‘practice-changing’ for newly diagnosed multiple myeloma

The article discusses the results of the phase 3 PERSEUS trial presented at ASH 2023. The trial showed that daratumumab combined with bortezomib, lenalidomide, and dexamethasone is more effective than the latter three drugs alone in treating newly diagnosed multiple myeloma patients. Chakra Chaulagain, MD, director of the myeloma and amyloidosis program at Cleveland Clinic…

Read More

The FDA must approve intranasal treatments for anaphylaxis

Millions of people, including children, suffer from life-threatening food allergies in the U.S. The most common treatment is an injectable epinephrine needle, but many people do not have access to or feel comfortable using it. There are alternatives, such as sublingual and intranasal epinephrine, but they are not widely available. Lawmakers and regulators need to…

Read More

Intersectionality in health equity research

The content discusses the importance of addressing overlapping systems of discrimination, particularly in the context of the COVID-19 pandemic. The pandemic has highlighted societal inequities, particularly in relation to people living in deprived areas and ethnic minorities. The early research focused on single categories of social identity, which concealed heterogeneity and failed to account for…

Read More

Prone positioning does not cut time to weaning in ARDS with VV-ECMO

A randomized clinical trial found that prone positioning does not decrease the time to successful weaning in patients with severe acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO). The trial involved 14 intensive care units and included patients with severe ARDS who were randomly assigned to prone or supine positioning. Ninety-four percent…

Read More
error: Content is protected !!